The Effect and Mechanism of Ligustilide Cycloprolactam on Inhibiting Apoptosis and Inflammation of Rat Chondrocytes
CHEN Xin1,2, WANG Xinyue3, LI Yuanzhen2, QI Xin1, XI Fangqin2, LI Ning1,2, LIU Junxi4, XIE Xingwen1,2*, LIU Jianjun1*
This study investigated the effect and mechanism of LIGc (ligustilide cycloprolactam) on apoptosis and inflammation of rat chondrocytes induced by IL-1β (10 ng/mL). Rat chondrocytes were divided into Control group, IL-1β group and LIGc high-dose, medium-dose and low-dose groups. Chondrocyte inflammation model was established by IL-1β induction in other groups except Control group. LIGc high-dose, medium-dose and low-dose groups were treated with 0.4, 0.2 and 0.1 μmol/mL LIGc for 24 h respectively. The effect of LIGc on the activity of rat chondrocytes was detected by CCK-8. The apoptosis of rat chondrocytes was observed by Hoechst 33258 staining. The protein expressions of Bcl-2, Caspase-3, TLR4 and NF-κB p65 were detected by Western blot. The expression levels of COX-2 and HMGB1 mRNA were detected by RT-qPCR. It was found that different concentrations of LIGc had no significant effect on the survival rate of rat chondrocytes. Compared with the Control group, the apoptosis of IL-1β group was significantly increased. The expression level of Caspase-3 protein was significantly increased (P<0.01), and the expression level of Bcl-2 protein was significantly decreased (P<0.01). The expression levels of COX-2 and HMGB1 genes were significantly increased (P<0.01); the expression levels of TLR4 and NF-κB p65 protein were significantly increased (P<0.01). After LIGc intervention, cell viability was significantly increased, cell apoptosis was inhibited, and the expression level of Caspase-3 protein was significantly decreased (P<0.01), the expression level of Bcl-2 protein LIGc (0.4, 0.2 μmol/mL) was significantly increased (P<0.01); the expression levels of COX-2 and HMGB1 genes were significantly decreased (P<0.01). The expression levels of TLR4 and NF-κB p65 protein were significantly decreased (P<0.01). Therefore, LIGc can inhibit the apoptosis and inflammatory response of chondrocytes induced by IL-1β, and its mechanism may be related to the inhibition of TLR4/NF-κB pathway